Skip to main content
Genesystem Co., Ltd logo

Genesystem Co., Ltd — Investor Relations & Filings

Ticker · 363250 ISIN · KR7363250002 KO Manufacturing
Filings indexed 173 across all filing types
Latest filing 2025-07-02 Major Shareholding Noti…
Country KR South Korea
Listing KO 363250

About Genesystem Co., Ltd

https://genesystem.co.kr/

Genesystem Co., Ltd. is a biotechnology engineering company specializing in the development and commercialization of molecular diagnostic solutions for point-of-care testing (POCT) applications. The company focuses on making Polymerase Chain Reaction (PCR) testing faster, simpler, and more accessible for on-site use. It develops and markets rapid PCR platforms, proprietary reagents, and biochip-based products. Key technologies include ultra-fast PCR, miniaturized heating modules, and multiplex biochip systems that enable precise and convenient analysis. Genesystem's solutions serve various markets, including human healthcare for pathogen detection and food safety for identifying foodborne pathogens and meat authentication.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Seo Yu-jin) and related parties in the company 'Jin System'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-07-02 Korean
단일판매ㆍ공급계약해지
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure from a Korean company (GeneSystem) regarding the termination of a single sales and supply contract. It details the contract value, the counterparty, the reason for termination (non-payment of advance), and the effective date. This type of material event disclosure is a standard regulatory filing in the Korean market (DART system) and does not fit into specific categories like M&A, dividends, or share repurchases. Therefore, it is classified as a general regulatory filing.
2025-07-01 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (GeneSystem) regarding a 'Correction Report' (정정신고) for a previously disclosed 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details changes to the investment judgment section due to a delay in advance payment. Since this is a specific regulatory disclosure regarding a material contract update that does not fit into categories like financial reports, dividends, or management changes, it falls under the general regulatory filing category.
2025-06-30 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Genesystem Co., Ltd.' covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial and operational information, including company overview, history, capital changes, and business objectives. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial and business data for a period shorter than a full fiscal year. Q1 2025
2025-05-14 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding an upcoming corporate investor relations (IR) event (기업설명회). It provides details such as the date, time, location, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it does not fit into specific categories like earnings releases or financial reports, it is classified as a general regulatory filing/announcement.
2025-05-14 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea used when an entity acquires a significant stake (typically 5% or more) in a publicly traded company. This document specifically details the acquisition of shares by Korea Securities Finance Corp in Jinsystem Co., Ltd. and falls under the category of Major Shareholding Notification.
2025-04-09 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.